Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 19/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10367296 | 0.94 | CXCR4 (0.51) | CXCR4CYP2D6CHRM2ADRA2ADRD2 | |
| SCHEMBL1698247 | 0.86 | CXCR4 (0.40) | CXCR4CYP2D6 | |
| SCHEMBL4350910 | 0.83 | CXCR4 (0.42) | CXCR4CYP2D6 | |
| SCHEMBL5574566 | 0.82 | CXCR4 (0.64) | CXCR4 | |
| SCHEMBL3310571 | 0.82 | CXCR4 (0.46) | CXCR4CYP2D6 | |
| SCHEMBL14037800 | 0.82 | CXCR4 (0.46) | CXCR4CYP2D6 | |
| SCHEMBL30584967 | 0.82 | CXCR4 (0.46) | CXCR4CYP2D6 | |
| SCHEMBL3950796 | 0.81 | HDAC1 (0.43) | CXCR4CYP2D6 | |
| SCHEMBL3948666 | 0.80 | HDAC1 (0.40) | CXCR4CYP2D6 | |
| SCHEMBL14071365 | 0.80 | CYP2D6 (0.42) | CXCR4CYP2D6DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230271961-A1 | Pan-Tropic Entry Inhibitors | UNIV EMORY (US) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271961-A1 | Pan-Tropic Entry Inhibitors | CXCR4, CCR5, CXCL12 | CXCR4 1/4885CYP2D6 3735/4885CHRM2 3239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.